Drug
Jtt 705 And Simvastatin
Jtt 705 And Simvastatin: highest development phase Phase 2, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| JTT-705 600 mg and simvastatin 40 mg NCT00688558 | Phase 2 | Dyslipidemia |
Latest
No recent events.
Follow Jtt 705 And Simvastatin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.